AZN vs EQT · P/E 28, $288.38B cap vs P/E 90, rev $5.19B
AstraZeneca PLC (AZN) versus EQT Corporation (EQT) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
EQT Corporation (EQT) is a oil & gas e&p company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported EQT revenue for 2026-06-30 was $5.19B. Net income was $1.70B. Revenue was up 53.6% from 2026-03-31 to 2026-06-30. EQT currently screens at market cap $32.85B and trailing P/E 90.0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. EQT currently screens at market cap $32.85B and trailing P/E 90.0.
Not investment advice. Open the AZN and EQT stock pages for the full models.
Not investment advice.